Abivax SA Sponsored ADR (ABVX)
NASDAQ:ABVX
Want to see ABVX full AI Analyst Report?
Total Valuation
Abivax SA Sponsored ADR has a market cap or net worth of $10.52B. The enterprise value is $8.55B.
Market Cap$10.52B
Enterprise Value$8.55B
Share Statistics
Abivax SA Sponsored ADR has 79,694,534 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding79,694,534
Owned by Insiders―
Owned by Institutions40.25%
Financial Efficiency
Abivax SA Sponsored ADR’s return on equity (ROE) is -0.74 and return on invested capital (ROIC) is -47.10%.
Return on Equity (ROE)-0.74
Return on Assets (ROA)-0.58
Return on Invested Capital (ROIC)-47.10%
Return on Capital Employed (ROCE)-0.47
Revenue Per Employee0.00
Profits Per Employee-4.68M
Employee Count69
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Abivax SA Sponsored ADR is ―. Abivax SA Sponsored ADR’s PEG ratio is -0.36.
PE Ratio―
PS Ratio0.00
PB Ratio17.54
Price to Fair Value17.54
Price to FCF-51.21
Price to Operating Cash Flow-48.64
PEG Ratio-0.36
Income Statement
In the last 12 months, Abivax SA Sponsored ADR had revenue of 0.00 and earned -336.10M in profits. Earnings per share was -4.65.
Revenue0.00
Gross Profit0.00
Operating Income-246.06M
Pretax Income-330.25M
Net Income-336.10M
EBITDA-300.70M
Earnings Per Share (EPS)-4.65
Cash Flow
In the last 12 months, operating cash flow was -137.90M and capital expenditures -55.00K, giving a free cash flow of -137.96M billion.
Operating Cash Flow-137.90M
Free Cash Flow-137.96M
Free Cash Flow per Share-1.73
Dividends & Yields
Abivax SA Sponsored ADR pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.50
52-Week Price Change1988.66%
50-Day Moving Average118.32
200-Day Moving Average109.28
Relative Strength Index (RSI)64.96
Average Volume (3m)975.08K
Important Dates
Abivax SA Sponsored ADR upcoming earnings date is Sep 14, 2026, During Market Hours (Confirmed).
Last Earnings DateMay 22, 2026
Next Earnings DateSep 14, 2026
Ex-Dividend Date―
Financial Position
Abivax SA Sponsored ADR as a current ratio of 8.75, with Debt / Equity ratio of 7.05%
Current Ratio8.75
Quick Ratio8.75
Debt to Market Cap<0.01
Net Debt to EBITDA1.61
Interest Coverage Ratio-8.64
Taxes
In the past 12 months, Abivax SA Sponsored ADR has paid 5.85M in taxes.
Income Tax5.85M
Effective Tax Rate-0.02
Enterprise Valuation
Abivax SA Sponsored ADR EV to EBITDA ratio is -24.93, with an EV/FCF ratio of -48.10.
EV to Sales0.00
EV to EBITDA-24.93
EV to Free Cash Flow-48.10
EV to Operating Cash Flow-48.14
Balance Sheet
Abivax SA Sponsored ADR has $530.16M in cash and marketable securities with $32.08M in debt, giving a net cash position of $498.08M billion.
Cash & Marketable Securities$530.16M
Total Debt$32.08M
Net Cash$498.08M
Net Cash Per Share$6.25
Tangible Book Value Per Share$6.18
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Abivax SA Sponsored ADR is $152.57, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$152.57
Price Target Upside26.97% Upside
Analyst ConsensusModerate Buy
Analyst Count7
Revenue Growth Forecast―
EPS Growth Forecast―